Philip Morris Intl. expands into cannabis via Avicanna partnership, focusing on medical research and innovation: How this ...

Philip Morris International Inc. (PM) stock saw a modest uptick, ending the day at $121.59 which represents a slight increase of $1.79 or 1.49% from the prior close of $119.8. The stock opened at $119 ...

Shares of Philip Morris extended their recent bounce Thursday after the U.S. Food and Drug Administration authorized the ...

Assenagon Asset Management S.A. lessened its holdings in shares of Philip Morris International Inc. (NYSE:PM – Free Report) ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

In a statement, the FDA said it has authorized the marketing and sale of Philip Morris International’s Zyn nicotine pouches.

Moody National Bank Trust Division grew its stake in shares of Philip Morris International Inc. (NYSE:PM – Free Report) by ...

Philip Morris International Inc. closed $16.60 below its 52-week high ($134.15), which the company reached on October 31st.

Learn how Philip Morris International plans to shift to smoke-free products by 2030 to mitigate risks, boost profits, and achieve strong financial growth.

Tobacco stocks gained slightly on Thursday after the FDA has authorized the marketing of 20 Zyn nicotine pouch products ...

IQOS's success in Egypt signals a promising opportunity for the introduction of additional smoke-free products to the market, ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...